ZHANG; Lianshan

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZHANG; Lianshan.The latest application filed is for "method for treating autoimmune disease by il-17 antagonist".

Company Profile

37.30.75

ZHANG; Lianshan - Lianyungang CN
Zhang; Lianshan - Jiangsu CN
Zhang; Lianshan - Shanghai CN
ZHANG; Lianshan - Minhang District CN
ZHANG; Lianshan - Princeton Junction NJ
Zhang; Lianshan - West Windsor NJ
Zhang; Lianshan - Carmel IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Treating Autoimmune Disease By Il-17 Antagonist App 20220267432 - SUN; Piaoyang ; et al.	2022-08-25
Use Of Anti-pd-1 Antibody In Combination With Famitinib In Preparation Of Drug For Treating Tumors App 20220251203 - Zhang; Lianshan ; et al.	2022-08-11
PD-1 antibody, antigen-binding fragment thereof, and medical application thereof Grant 11,365,255 - Yuan , et al. June 21, 2	2022-06-21
Bispecific Protein App 20220153853 - Cao; Zhuoxiao ; et al.	2022-05-19
Use of Combination of Anti-PD-1 Antibody and VEGFR Inhibitor in Preparation of Drug for Treating Cancers App 20220119528 - Sun; Xing ; et al.	2022-04-21
Use Of Il-15 Protein Complex Joint Pd-l1 Antibody For Treating Tumor Diseases App 20220111008 - Sun; Xing ; et al.	2022-04-14
Anti-cd40 Antibody, Antigen Binding Fragmentand Pharmaceutical Use Thereof App 20220025060 - LIAO; Cheng ; et al.	2022-01-27
Use Of Tim-3 Antibody In Preparation Of Medicines For Treating Tumors App 20220017618 - Sun; Xing ; et al.	2022-01-20
Lag-3 Antibody, Antigen-binding Fragment Thereof, And Pharmaceutical Application Thereof App 20220002405 - Cao; Zhuoxiao ; et al.	2022-01-06
Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of drug for treating cancers Grant 11,208,484 - Sun , et al. December 28, 2	2021-12-28
Anti-4-1bb Antibody, Antigen-binding Fragment Thereof And Medical Use Thereof App 20210363266 - HUANG; Hao ; et al.	2021-11-25
Ligand-drug Conjugate Of Exatecan Analogue, Preparation Method Therefor And Application Thereof App 20210353764 - XU; Jianyan ; et al.	2021-11-18
An Anti-ox40 Antibody, Antigen-binding Fragment Thereof, And The Pharmaceutical Use App 20210355229 - Liao; Cheng ; et al.	2021-11-18
LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereof Grant 11,155,617 - Cao , et al. October 26, 2	2021-10-26
Human Il-4r Binding Antibody, Antigen Binding Fragment Thereof, And Medical Use Thereof App 20210238294 - LIAO; Cheng ; et al.	2021-08-05
Use of EZH2 inhibitor combined with BTK inhibitor in preparing drug for treating tumor Grant 11,065,239 - Ma , et al. July 20, 2	2021-07-20
Use Of Cdk4/6 Inhibitor In Combination With Egfr Inhibitor In The Preparation Of Medicament For Treating Tumor Diseases App 20210196719 - ZHANG; Lei ; et al.	2021-07-01
Use of combination of VEGFR inhibitor and PARP inhibitor in preparation of medicament for treating gastric cancer Grant 11,000,518 - Jiang , et al. May 11, 2	2021-05-11
Interleukin 15 Protein Complex and Use Thereof App 20210106655 - QU; Xiangdong ; et al.	2021-04-15
B7-H3 Antibody, Antigen-Binding Fragment Thereof And Medical Use Thereof App 20210101984 - GU; Jinming ; et al.	2021-04-08
Use Of Ezh2 Inhibitor Combined With Btk Inhibitor In Preparing Drug For Treating Tumor App 20210030736 - MA; Ke ; et al.	2021-02-04
Interleukin 15 protein complex Grant 10,905,743 - Qu , et al. February 2, 2	2021-02-02
B7-H3 antibody, antigen-binding fragment thereof and medical use thereof Grant 10,899,837 - Gu , et al. January 26, 2	2021-01-26
Anti-CD27 Antibody, Antigen-binding Fragment Thereof, and Medical Use Thereof App 20210009706 - Huang; Hao ; et al.	2021-01-14
Stable Anti-pd-1 Antibody Pharmaceutical Preparation And Application Thereof In Medicine App 20210000954 - Li; Jie ; et al.	2021-01-07
Pd-l1 Antibody, Antigen-binding Fragment Thereof And Medical Application Thereof App 20200399375 - Qu; Xiangdong ; et al.	2020-12-24
Method for preventing or treating tumor diseases with a combination of tyrosine kinase inhibitor and CDK4/6 inhibitor Grant 10,857,146 - Jiang , et al. December 8, 2	2020-12-08
Use Of Kor Agonist In Combination With Mor Agonist In Preparing Drug For Treating Pain App 20200368309 - HUANG; Xiaoxing ; et al.	2020-11-26
PD-L1 antibody, antigen-binding fragment thereof and medical application thereof Grant 10,815,304 - Qu , et al. October 27, 2	2020-10-27
PCSK9 antibody, antigen-binding fragment thereof, and medical application thereof Grant 10,793,643 - Qu , et al. October 6, 2	2020-10-06
Stable anti-PD-1 antibody pharmaceutical preparation and application thereof in medicine Grant 10,786,567 - Li , et al. September 29, 2	2020-09-29
Pcsk9 Antibody, Antigen-binding Fragment Thereof, And Medical Uses Thereof App 20200270365 - QU; Xiangdong ; et al.	2020-08-27
Anti-cd40 Antibody, Antigen Binding Fragment Thereof And Medical Use Thereof App 20200148778 - Yan; Shude ; et al.	2020-05-14
Anti-gitr Antibody, Antigen-binding Fragment Thereof, And Pharmaceutical Use Thereof App 20200131263 - YAN; Shude ; et al.	2020-04-30
Method For Preventing Or Treating Tumor Diseases With A Combination Of Tyrosine Kinase Inhibitor And Cdk4/6 Inhibitor App 20200061049 - Jiang; Jiahua ; et al.	2020-02-27
Pharmaceutical Composition Containing Mor Agonist And Kor Agonist, And Uses Thereof App 20200054594 - NIU; Zhuolu ; et al.	2020-02-20
Medical Use Of Anti-c Met Antibody-cytotoxic Drug Conjugate App 20200054764 - SUN; Xing ; et al.	2020-02-20
Ligand-cytotoxic drug conjugate, preparation method thereof, and uses thereof Grant 10,562,977 - Wang , et al. Feb	2020-02-18
Use of Combination of Anti-PD-1 Antibody and VEGFR Inhibitor in Preparation of Drug for Treating Cancers App 20200040078 - SUN; Xing ; et al.	2020-02-06
B7-h3 Antibody, Antigen-binding Fragment Thereof And Medical Use Thereof App 20200031934 - GU; Jinming ; et al.	2020-01-30
Method For Preparing Antibody-drug Conjugate App 20200030453 - Liu; Yupeng ; et al.	2020-01-30
Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereof Grant 10,543,284 - Liu , et al. Ja	2020-01-28
Anti-sclerostin antibody, antigen binding fragment and medical use thereof Grant 10,449,250 - Liu , et al. Oc	2019-10-22
Thrombin Antibody, Antigen-binding Fragment And Pharmaceutical Use Thereof App 20190315886 - YING; Hua ; et al.	2019-10-17
Pd-1 Antibody, Antigen-binding Fragment Thereof, And Medical Application Thereof App 20190309069 - YUAN; Jijun ; et al.	2019-10-10
Use Of Combination Of Vegfr Inhibitor And Parp Inhibitor In Preparation Of Medicament For Treating Gastric Cancer App 20190275021 - JIANG; Jiahua ; et al.	2019-09-12
Lag-3 Antibody, Antigen-binding Fragment Thereof, And Pharmaceutical Application Thereof App 20190233513 - Cao; Zhuoxiao ; et al.	2019-08-01
Anti-cd27 Antibody, Antigen-binding Fragment Thereof, And Medical Use Of Same App 20190225698 - YAN; Shude ; et al.	2019-07-25
PD-1 antibody, antigen-binding fragment thereof, and medical application thereof Grant 10,344,090 - Yuan , et al. July 9, 2	2019-07-09
Interleukin 15 Protein Complex And Use Thereof App 20190070264 - QU; Xiangdong ; et al.	2019-03-07
IL-15 heterodimeric protein and uses thereof Grant 10,206,980 - Qu , et al. Feb	2019-02-19
Pcsk9 Antibody, Antigen-binding Fragment Thereof, And Medical Application Thereof App 20190016825 - QU; Xiangdong ; et al.	2019-01-17
Stable Anti-pd-1 Antibody Pharmaceutical Preparation And Application Thereof In Medicine App 20180339045 - LI; Jie ; et al.	2018-11-29
Pd-l1 Antibody, Antigen-binding Fragment Thereof And Medical Application Thereof App 20180334504 - QU; Xiangdong ; et al.	2018-11-22
Ligand-cytotoxic Drug Conjugate, Preparation Method Thereof, And Use Thereof App 20180177890 - XU; Jianyan ; et al.	2018-06-28
Anti-c-met Antibody And Anti-c-met Antibody-cytotoxic Drug Conjugate And Pharmaceutical Use Thereof App 20180110875 - LIU; Jiajian ; et al.	2018-04-26
Anti-sclerostin Antibody, Antigen Binding Fragment And Medical Use Thereof App 20180099046 - LIU; Jiajian ; et al.	2018-04-12
IL-17A binding agent and uses thereof Grant 9,862,765 - Zhang , et al. January 9, 2	2018-01-09
Il-15 Heterodimeric Protein And Uses Thereof App 20170020963 - QU; Xiangdong ; et al.	2017-01-26
Ligand-cytotoxic Drug Conjugate, Preparation Method Thereof, And Uses Thereof App 20170002090 - WANG; Yali ; et al.	2017-01-05
Pd-1 Antibody, Antigen-binding Fragment Thereof, And Medical Application Thereof App 20160376367 - Yuan; Jijun ; et al.	2016-12-29
Human Relaxin Analogue, Pharmaceutical Composition Of Same, And Pharmaceutical Application Of Same App 20160326230 - ZHANG; Lianshan ; et al.	2016-11-10
Il-17a Binding Agent And Uses Thereof App 20160289321 - ZHANG; Lianshan ; et al.	2016-10-06
Human insulin analogue and acylated derivative thereof Grant 9,458,219 - Sun , et al. October 4, 2	2016-10-04
Glucagon Superfamily Peptides Exhibiting G Protein-coupled Receptor Activity App 20160051688 - DiMARCHI; Richard D. ; et al.	2016-02-25
Pegylated Insulin Lispro Compounds App 20150297681 - Beals; John Michael ; et al.	2015-10-22
Glucagon superfamily peptides exhbiting G protein coupled receptor activity Grant 9,145,451 - DiMarchi , et al. September 29, 2	2015-09-29
Quinazolinediones and their use Grant 9,090,568 - Liu , et al. July 28, 2	2015-07-28
PEGylated insulin lispro compounds Grant 9,050,371 - Beals , et al. June 9, 2	2015-06-09
Human Insulin Analogue And Acylated Derivative Thereof App 20140329745 - Sun; Piaoyang ; et al.	2014-11-06
Quinazolinediones And Their Use App 20140031358 - Liu; Dong ; et al.	2014-01-30
Glucagon Superfamily Peptides Exhbiting G Protein Coupled Receptor Activity App 20130116172 - Dimarchi; Richard D. ; et al.	2013-05-09
GLP-1 pegylated compounds Grant 8,183,340 - Glaesner , et al. May 22, 2	2012-05-22
Pegylated Insulin Lispro Compounds App 20110105392 - Beals; John Michael ; et al.	2011-05-05
Selective VPAC2 receptor peptide agonists Grant 7,897,573 - Bokvist , et al. March 1, 2	2011-03-01
Selective Vpac2 Receptor Peptide Agonists App 20100048460 - Zhang; Lianshan ; et al.	2010-02-25
Selective Vpac2 Receptor Peptide Agonists App 20100009916 - BOKVIST; BENGT KRISTER ; et al.	2010-01-14
Pegylated Insulin Lispro Compounds App 20090312236 - Beals; John Michael ; et al.	2009-12-17
Selective VPAC2 receptor peptide agonists Grant 7,582,608 - Bokvist , et al. September 1, 2	2009-09-01
Glp-1 Pegylated Compounds App 20090215981 - Glaesner; Wolfgang ; et al.	2009-08-27
Polyethylene glycol linked GLP-1 compounds Grant 7,557,183 - DiMarchi , et al. July 7, 2	2009-07-07
Selective Vpac2 Receptor Peptide Agonists App 20090118167 - Bokvist; Bengt Krister ; et al.	2009-05-07
Selective Vpac2 Receptor Peptide Agonists App 20090082276 - Zhang; Lianshan ; et al.	2009-03-26
Extended glucagon-like peptide-1 analogs Grant 7,482,321 - Glaesner , et al. January 27, 2	2009-01-27
Selective Vpac2 Receptor Peptide Agonists App 20080318845 - Bokvist; Bengt Krister ; et al.	2008-12-25
Selective Vpac2 Receptor Peptide Agonists App 20080234198 - Bokvist; Bengt Krister ; et al.	2008-09-25
Selective Apac2 Receptor Peptide Agonists App 20080194482 - Alsina-Fernandez; Jorge ; et al.	2008-08-14
Selective Vpac2 Receptor Peptide Agonists App 20080146500 - Bokvist; Bengt Krister ; et al.	2008-06-19
Polyethylene Glycol Linked Glp-1 Compounds App 20080113905 - DiMarchi; Richard Dennis ; et al.	2008-05-15
Selective Vpac2 Receptor Peptide Agonists App 20080096811 - Bokvist; Bengt Krister ; et al.	2008-04-24
Selective Vpac2 Receptor Peptide Agonists App 20080085860 - Bokvist; Bengt Krister ; et al.	2008-04-10
Selective Vpac2 Receptor Reptide Agonists App 20080026996 - Bokvist; Bengt Krister ; et al.	2008-01-31
Melanocortin receptor 4 (mc4) agonists and their uses App 20070105759 - Flora; David Benjamin ; et al.	2007-05-10
Glucagon-like peptide-1 analogs App 20060252693 - Glaesner; Wolfgang ; et al.	2006-11-09
Modified glucagon-like peptide-1 analogs App 20060252916 - DiMarchi; Richard Dennis ; et al.	2006-11-09
Insulin analogs having protracted time action App 20060217290 - Kohn; Wayne David ; et al.	2006-09-28
Glucagon-like peptide-1 analogs Grant 7,101,843 - Glaesner , et al. September 5, 2	2006-09-05
Extended glucagon-like peptide-1 analogs App 20060014241 - Glaesner; Wolfgang ; et al.	2006-01-19
Insulin molecule having protracted time action App 20050014679 - Beals, John Michael ; et al.	2005-01-20
Glucagon-like peptide-1analogs App 20040198654 - Glaesner, Wolfgang ; et al.	2004-10-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.